Skip to main content
SpringerLink
Log in

Authors’ Reply to Cappello et al. Comment on: “Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System”

  • Letter to the Editor
  • Published:
Drug Safety Aims and scope Submit manuscript

The Original Article was published on 12 August 2023

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cappello E, Valdiserra G, Bonaso M, Ferraro S, Convertino I, Tuccori M. Comment on: “Deliberate self-poisoning: real-time characterization of suicidal habits and toxidromes in the Food and Drug Administration Adverse Event Reporting System”. Drug Saf. 2023. https://doi.org/10.1007/s40264-023-01330-3

  2. Fusaroli M, Pelletti G, Giunchi V, Pugliese C, Bartolucci M, Necibi EN, et al. Deliberate self-poisoning: real-time characterization of suicidal habits and toxidromes in the Food and Drug Administration Adverse Event Reporting System. Drug Saf. 2023. https://doi.org/10.1007/s40264-022-01269-x.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Roy S, Charreteur R, Peries M, Kheloufi F, Eiden C, Nagot N, et al. Abuse and misuse of second-generation antipsychotics: an analysis using VigiBase, the World Health Organisation pharmacovigilance database. Br J Clin Pharmacol. 2022;88:4646–53.

    Article  CAS  PubMed  Google Scholar 

  4. Robert M, Jouanjus E, Khouri C, Fouilhé Sam-Laï N, Revol B. The opioid epidemic: a worldwide exploratory study using the WHO pharmacovigilance database. Addiction. 2023;118:771–5.

    Article  PubMed  Google Scholar 

  5. Carnovale C, Mazhar F, Pozzi M, Gentili M, Clementi E, Radice S. A characterization and disproportionality analysis of medication error related adverse events reported to the FAERS database. Expert Opin Drug Saf. 2018;17:1161–9.

    Article  CAS  PubMed  Google Scholar 

  6. Gentile G, Jego M, Spadari M, Griffiths K, Jouanjus E, Micallef J. Identification and tracking of Addictovigilance signals in general practice: which interactions between the general practitioners and the French Addictovigilance Network? Fundam Clin Pharmacol. 2018;32:643–51.

    Article  CAS  PubMed  Google Scholar 

  7. Smith SM, Dart RC, Katz NP, Paillard F, Adams EH, Comer SD, et al. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain. 2013;154:2287–96.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Singier A, Noize P, Berdaï D, Daveluy A, Arnaud M, Molimard M, et al. Medicine misuse: a systematic review and proposed hierarchical terminology. Br J Clin Pharmacol. 2021;87:1695–704.

    Article  PubMed  Google Scholar 

  9. Schulz M, Schmoldt A, Andresen-Streichert H, Iwersen-Bergmann S. Revisited: therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics. Crit Care. 2020;24:195.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmacology Unit, Department of Medical and Surgical Sciences, University of Bologna, Via Irnerio 48, Bologna, 40126, Italy

    Michele Fusaroli, Valentina Giunchi, Emanuel Raschi, Fabrizio De Ponti & Elisabetta Poluzzi

  2. Legal Medicine Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy

    Guido Pelletti & Susi Pelotti

Authors
  1. Michele Fusaroli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Guido Pelletti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Valentina Giunchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Emanuel Raschi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fabrizio De Ponti
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Susi Pelotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Elisabetta Poluzzi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michele Fusaroli.

Ethics declarations

Funding

No specific funding supported this research.

Conflicts of Interest

Michele Fusaroli, Guido Pelletti, Valentina Giunchi, Emanuel Raschi, Fabrizio De Ponti, Susi Pelotti, and Elisabetta Poluzzi have no conflicts of interest specific to this research.

Ethics Approval

Not applicable.

Consent to Participate

Not applicable.

Consent for Publication

Not applicable.

Availability of Data and Material

Not applicable.

Code Availability

Not applicable.

Authors’ Contributions

MF wrote the original draft. All the authors read, revised, and approved the final version.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fusaroli, M., Pelletti, G., Giunchi, V. et al. Authors’ Reply to Cappello et al. Comment on: “Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System”. Drug Saf 46, 919–920 (2023). https://doi.org/10.1007/s40264-023-01331-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40264-023-01331-2

Search

Navigation